July 30, 2026 · American journal of obstetrics and gynecology · DOI: 10.1016/j.ajog.2026.07.026

Abnormal serum sFlt-1 and PlGF as markers of occult placental dysfunction and fetal risk in pregestational diabetes: A Prospective Masked Cohort Study

Listen to this summary

The authors aimed to determine the prevalence of angiogenic biomarker abnormalities (sFlt-1 and PlGF) in pregnant individuals with pregestational diabetes and their association with adverse perinatal outcomes. They found that these biomarkers can predict complications such as preterm birth and preeclampsia, independent of fetal size, suggesting that routine measurement of these biomarkers could enhance fetal surveillance protocols.

Ruth C E Hughes, Jonathan A Williman, Gene Lee, Daniel Mackay

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play